X-ZELL is a pioneering medical technology company specializing in Next-Generation Cytology (NGC), a platform that integrates rapid laboratory processing with high-speed digital imaging to deliver same-day cancer diagnoses from minimally invasive samples. This innovative approach streamlines the diagnostic process, reducing turnaround times and enhancing the accuracy of cytological assessments.
Key Features and Functionality:
- Cryoimmunostaining™ Suite: A patented two-instrument slide staining system optimized for liquid samples, including bronchoalveolar lavage, pleural effusion, and fine-needle aspirates. It operates at sub-zero temperatures to preserve sample integrity and utilizes proprietary buffers and reagents. The suite comprises:
- Cryofixator™: Replaces complex sample preparation processes with non-toxic direct-to-slide fixation, conserving cell morphology, DNA, and RNA content.
- Cryostainer™: A slide-based immunofluorescence staining system accommodating up to eight fluorophore-conjugated antibodies on a single slide, maximizing data output while reducing antibody usage.
- Hybrid Microscope: A proprietary workstation that allows evaluation of multiple fluorescence channels side-by-side, enabling real-time digital visualization and comparison of conspicuous cells.
- hMX™ Cell Separation System: Gently removes leukocytes from whole blood to expose single atypical cells, preparing them for downstream Cryoimmunostaining™, thereby enhancing the detection of rare cells.
Primary Value and User Solutions:
X-ZELL's NGC platform addresses the limitations of traditional cytology by providing a rapid, data-rich workflow that reduces turnaround times to under four hours and decreases manual handling by up to 50%. By enabling the detection and digital processing of atypical cells from minimally invasive samples, X-ZELL enhances diagnostic accuracy and efficiency, facilitating early cancer detection and personalized patient care. This advancement is particularly beneficial in routine cytology laboratories, where timely and precise diagnostics are critical.